文献速递中医骨伤中药与中成药合理使用

4D无标记定量蛋白质组学筛选健骨颗粒治疗去卵巢骨质疏松大鼠的潜在靶点

4D label-free quantitative proteomics analysis to screen potential drug targets of Jiangu Granules treatment for postmenopausal osteoporotic rats.
PubMed 文献 · Front Pharmacol · 2022-11-01

本研究用4D无标记定量蛋白质组学分析去卵巢骨质疏松大鼠腰椎骨组织,比较假手术组、去卵巢组和健骨颗粒治疗组的差异表达蛋白。结果鉴定出健骨颗粒可能通过调控与成骨细胞分化相关的6个靶蛋白发挥治疗作用,为临床应用提供实验依据。

要点

  • 健骨颗粒可能通过调控成骨细胞分化相关靶蛋白改善去卵巢大鼠骨质疏松。
  • 研究采用4D无标记定量蛋白质组学,样本为3月龄SD雌性大鼠每组3只。
  • 鉴定了去卵巢与健骨颗粒治疗交集差异蛋白中的6个潜在靶蛋白。

核心结论

  • 健骨颗粒可能通过调节与成骨细胞分化相关的靶蛋白表达水平,增强去卵巢大鼠的成骨细胞分化而发挥治疗作用。

研究设计与样本

  • 研究建立双侧卵巢切除的PMOP大鼠模型,将9只3月龄SPF级雌性SD大鼠随机分为假手术组、去卵巢组和健骨颗粒治疗组,每组3只。
  • 取三组大鼠腰椎L3、L4骨组织提取蛋白,进行4D无标记定量蛋白质组学分析。
  • 将健骨颗粒治疗后差异表达蛋白与去卵巢后差异表达蛋白取交集,筛选与健骨颗粒治疗PMOP机制相关的蛋白。

主要发现

  • 假手术组与去卵巢组比较,有104个上调差异表达蛋白和153个下调差异表达蛋白。
  • 假手术组与健骨颗粒治疗组比较,有107个上调差异表达蛋白和113个下调差异表达蛋白。
  • 去卵巢组与健骨颗粒治疗组比较,有15个上调差异表达蛋白和32个下调差异表达蛋白。
  • 通过取假手术组vs去卵巢组和去卵巢组vs健骨颗粒治疗组的差异蛋白交集,鉴定出6个健骨颗粒调控去卵巢大鼠成骨细胞分化的潜在靶蛋白。

临床怎么用

  • 本研究为实验研究,结果提示健骨颗粒治疗PMOP可能涉及成骨细胞分化相关靶蛋白,可为临床应用于PMOP提供实验依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: Postmenopausal osteoporosis (PMOP) is a disease with a high prevalence in postmenopausal women and is characterized by an imbalance in bone metabolism, reduced bone mass, and increased risk of fracture due to estrogen deficiency. Jiangu granules (JG) is a compound prescription used in traditional Chinese medicine to treat PMOP. However, its definitive mechanism in PMOP is unclear. This study used a 4D label-free quantitative proteomics method to explore the potential therapeutic mechanism of JG in an ovariectomy (OVX) rats' model. Materials and methods: A rat model of PMOP was established by removing the ovaries bilaterally. Nine 3-month-old specific-pathogen-free female SD rats. The nine rats were randomly divided into 3 groups (n = 3 in each group): the sham-operated group (J), the ovariectomy group (NC), and the JG treatment (ZY) group. Proteins extracted from the bone tissue of the lumbar spine (L3, L4) of three groups of rats were analyzed by 4D label-free quantitative proteomics, and proteins differentially expressed after JG treatment and proteins differentially expressed after de-ovulation were intersected to identify proteins associated with the mechanism of PMOP by JG treatment. Result: There were 104 up-regulated and 153 down-regulated differentially expressed proteins (DEPs) in the J group vs. NC group, 107 up-regulated and 113 down-regulated DEPs in the J group vs. ZY group, and 15 up-regulated and 32 down-regulated DEPs in the NC group vs. ZY group. Six potential target proteins for JG regulation of osteoblast differentiation in OVX rats were identified by taking intersections of differential proteins in the J group vs. NC group and NC group vs. ZY group. Conclusion: JG may exert therapeutic effects by modulating the expression levels of target proteins associated with osteoblast differentiation to enhance osteoblast differentiation in OVX rats. These results further uncovered the target proteins and specific mechanisms of JG in treating PMOP, providing an experimental basis for the clinical application of JG in treating PMOP.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Lin H, Zhang W, Xu Y, et al. 4D label-free quantitative proteomics analysis to screen potential drug targets of Jiangu Granules treatment for postmenopausal osteoporotic rats. Front Pharmacol. 2022. PMID: 36386173. doi:10.3389/fphar.2022.1052922

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。